Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single‐center prospective study
Journal of Digestive Diseases · 2024-05 · 25 (5) · 279-284
DOI: 10.1111/1751-2980.13289 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Digestive Diseases, online erschienen am 20.06.2024. Verfasst von Annalisa Schiepatti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Cholestyramine Resin, Diarrhea, Bile Acids and Salts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
We aimed to evaluate the clinical response to cholestyramine in patients with functional chronic diarrhea and a high clinical suspicion of bile‐acid diarrhea (BAD) investigated with 75‐selenium homocholic acid taurine (SeHCAT) test.
Methods
Adult patients attending our outpatient clinic between January and December 2021 for chronic diarrhea with suspicion of BAD were proposed SeHCAT testing and a therapeutic trial of cholestyramine 4–8 g daily. Clinical response to cholestyramine was evaluated at 1, 3, 6, and 12 months. Clinical and demographic data were analyzed according to SeHCAT test results.
Results
Among the 50 patients with chronic diarrhea and clinical suspicion of BAD, 13 (26.0%) refused either SeHCAT testing or cholestyramine therapy. Finally, 37 patients (31 females, age 44 ± 14 years) agreed to undergo SeHCAT and were started on cholestyramine (median follow‐up 14 months [interquartile range 6–16 months]). Initial response to cholestyramine was similar in patients with positive and negative SeHCAT test results, but improved over time in those with a positive test result. Long‐term response (100% vs 65.2%, P = 0.02) and necessity of maintenance therapy for symptom control were more common in those with positive SeHCAT test result (71.4% vs 26.1%, P = 0.02). However, response to cholestyramine was also frequent in patients with a negative test result.
Conclusions
The SeHCAT test accurately identifies patients with BAD who benefit from long‐term cholestyramine treatment. Nevertheless, cholestyramine may be also effective in patients with chronic diarrhea but negative SeHCAT test result.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
- Gastroenterology Unit of Pavia Institute, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
- Nuclear Medicine Unit, Istituti Clinici Scientifici Maugeri SpA SB IRCCS, Pavia, Italy.
- Department of Health Sciences, University of Milan, Milan, Italy.
- Medical Physics Unit, Istituti Clinici Scientifici Maugeri SpA SB IRCCS, Pavia, Italy.
ORCID-Profile: Annalisa Schiepatti, Stiliano Maimaris, Federico Biagi
Zitieren
APA
Schiepatti, A., Bossert, I., Cincotta, M., Zanini, C. A., Maimaris, S., D'Ambrosio, D., Trifirò, G., & Biagi, F. (2024). Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single‐center prospective study. Journal of Digestive Diseases, 25(5), 279-284. https://doi.org/10.1111/1751-2980.13289
Vancouver
Schiepatti A, Bossert I, Cincotta M, Zanini CA, Maimaris S, D'Ambrosio D, et al. Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single‐center prospective study. Journal of Digestive Diseases. 2024;25(5):279-284. doi:10.1111/1751-2980.13289
BibTeX
@article{Schiepatti2024,
author = {Schiepatti, Annalisa and Bossert, Irene and Cincotta, Marta and Zanini, Carolina Arianna and Maimaris, Stiliano and D'Ambrosio, Daniela and Trifirò, Giuseppe and Biagi, Federico},
title = {Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single‐center prospective study},
journal = {Journal of Digestive Diseases},
year = {2024},
volume = {25},
number = {5},
pages = {279--284},
doi = {10.1111/1751-2980.13289}
}
EUVIMED